The Effect of long-term rapamycin administration on intracellular calcium quantification and RhoA activity in kainic acid epilepsy model
DOI:
https://doi.org/10.1590/Keywords:
Rapamycin, Calcium, RhoA activity, Organotypic hippocampal slice culture , Epilepsy, Kainic acidAbstract
Epilepsy affects around 50 million people worldwide, with 30% of them being refractory epilepsy. This shows that there is still a need for novel anti-seizure medication that have different mechanisms. One of the most common types of refractory epilepsy is temporal lobe epilepsy. Among the several effects of seizures on neurons is an increase in intracellular Ca2+ and activation of RhoA. Rapamycin is mTORC1 inhibitor, but long-term exposure to rapamycin (>18 hours) could also inhibit mTORC2. RhoA signaling pathway is regulated through the mTORC2 pathway; thus we hypothesized that long-term exposure to rapamycin could inhibit intracellular Ca2+ and RhoA activity as one of the mTORC2 downstream proteins, in a temporal lobe epilepsy model. This study used organotypic hippocampal slice cultures (OHSC) which were exposed to 20 nM rapamycin treatment for 3, 5, 8, and 10 days after induction of epilepsy by 7 μM kainic acid administration for 48 hours. Intracellular calcium concentration was observed using CLSM and RhoA activity with western blot. The results obtained from this research were long-term administration of rapamycin can decrease intracellular calcium concentration and RhoA activity in OHSC models of epilepsy induced by kainic acid, with the most effective duration is 5 days of exposure to rapamycin.
Downloads
References
Banerjee R, Ghosh AK, Mondal AC. Effects of chronic stress and antidepressant treatment on behavioral, physiological and neurochemical aspects in male and female rats. Al Ameen J Med Sci. 2012;5(2):165-76.
Bausch SB, McNamara JO. Contributions of mossy fiber and CA1 pyramidal cell sprouting to dentate granule cell hyperexcitability in kainic acid-treated hippocampal slice cultures. J Neurophysiolo. 2004;92(6):3582-3595.
Ben-Ari Y. Kainate and temporal lobe epilepsies: three decades of progress. Epilepsia. 2010;51:40.
Blazejczyk M, Macias M, Korostynski M, Firkowska M, Piechota M, Skalecka A, et al. Kainic acid induces mTORC1-dependent expression of Elmo1 in hippocampal neurons. Mol Neurobiol. 2017;54(4):2562-78.
Chen W, Chen W, Li XC, Ghobrial RM, Kloc M. Coinhibition of mTORC1/mTORC2 and RhoA/ROCK pathways prevents chronic rejection of rat cardiac allografts. Transplantation Reports. 2018;3(4):21-8.
Coan AC, Kobayashi E, Lopes-Cendes I, Li LM, Cendes F. Abnormalities of hippocampal signal intensity in patients with familial mesial temporal lobe epilepsy. Braz J Med Biol Res. 2004;37:827-32.
Engelborghs S, D’hooge R, De Deyn PP. Pathophysiology of epilepsy. Acta Neurol Belg. 2000;100(4):201-213.
Hodges SL, Lugo JN. Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy. Epilepsy Res. 2020;161:106282.
Kaftan E, Marks AR, Ehrlich BE. Effects of rapamycin on ryanodine receptor/Ca2+-release channels from cardiac muscle. Circ Res. 1996;78(6):990-7.
Katzung BG, Trevor AJ. Basic and clinical pharmacology. 13th edition. San Fransisco: McGraw-Hill; 2015.
Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84(2):275-91.
Liu L, Luo Y, Chen L, Shen T, Xu B, Chen W, et al. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity. J Biol Chem. 2010;285(49):38362-38373.
Magalhães DM, Pereira N, Rombo DM, Beltrão-Cavacas C, Sebastião AM, Valente CA. Ex vivo model of epilepsy in organotypic slices-a new tool for drug screening. J Neuroinflammation. 2018;15:1-8.
Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nat Aging. 2023;3(6):642-60.
Moalong KM, Espiritu AI, Fernandez ML, Jamora RD. Treatment gaps and challenges in epilepsy care in the Philippines. Epilepsy Behav. 2021;115:107491.
Pitkänen A, Galanopoulou AS, Moshé SL. Models of seizures and epilepsy. London: Academic Press; 2017.
Routbort MJ, Bausch SB, McNamara JO. Seizures, cell death, and mossy fiber sprouting in kainic acid-treated organotypic hippocampal cultures. Neuroscience. 1999;94(3):755-65.
Ruan B, Pong K, Jow F, Bowlby M, Crozier RA, Liu D, et al. Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities. Proc Nat Acad Sci. 2008;105(1):33-38.
Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell. 2006;22(2):159-68.
Semenova MM, Mäki-Hokkonen AM, Cao J, Komarovski V, Forsberg KM, Koistinaho M, et al. Rho mediates calcium-dependent activation of p38α and subsequent excitotoxic cell death. Nat Neurosci. 2007;10(4):436-443.
Sharma AK, Searfoss GH, Reams RY, Jordan WH, Snyder PW, Chiang AY, et al. Kainic acid-induced F-344 rat model of mesial temporal lobe epilepsy: gene expression and canonical pathways. Toxicol Pathol. 2009;37(6):776-789.
Switon K, Kotulska K, Janusz-Kaminska A, Zmorzynska J, Jaworski J. Molecular neurobiology of mTOR. Neuroscience. 2017;341:112-153.
Terashima A, Taniguchi T, Nakai M, Yasuda M, Kawamata T, Tanaka C. Rapamycin and FK506 induce long-term potentiation by pairing stimulation via an intracellular Ca2+ signaling mechanism in rat hippocampal CA1 neurons. Neuropharmacology. 2000;39(10):1920-8.
Wang Z, Ren D, Zheng P. The role of Rho/ROCK in epileptic seizure-related neuronal damage. Metab Brain Dis. 2022;37(4):881-7.
Weichhart T. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Totowa: Humana Totowa; 2012. 1-4 p.
World Health Organization. Epilepsy: a public health imperative Geneva, Switzerland; 2019.
Xiang Y, Niu Y, Xie Y, Chen S, Zhu F, Shen W, et al. Inhibition of RhoA/Rho kinase signaling pathway by fasudil protects against kainic acid-induced neurite injury. Brain Behav. 2021;11(8):2266.
Ye Q, Zeng C, Dong L, Wu Y, Huang Q, Wu Y. Inhibition of ferroptosis processes ameliorates cognitive impairment in kainic acid-induced temporal lobe epilepsy in rats. Am J Transl Res. 2019;11(2):875.
Yuan J, Wang LY, Li JM, Cao NJ, Wang L, Feng GB, et al. Altered expression of the small guanosine triphosphatase RhoA in human temporal lobe epilepsy. J Mol Neurosci. 2010;42:53-58.
Zhang X, Qiao Z, Liu N, Gao L, Wei L, Liu A, et al. Stereotypical patterns of epileptiform calcium signal in hippocampal CA1, CA3, dentate gyrus, and entorhinal cortex in freely moving mice. Sci Rep. 2019;9(1):1-9.
Zhang XM, Zhu J. Kainic acid-induced neurotoxicity: targeting glial responses and glia-derived cytokines. Curr Neuropharmacol. 2011;9(2):388-398.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
